Advanced Surgical Equipment
Minimally Invasive Surgery
Iterative DevelopmentActive
Key Facts
About Stryker
Stryker is a mature, large-cap medical device leader with a market valuation exceeding $126 billion, publicly traded on the NYSE under the ticker SYK. Its core business is segmented into Orthopaedics (joint replacements, trauma, extremities), MedSurg (surgical equipment, endoscopy, patient handling), and Neurotechnology (neurosurgery, neurovascular, spine). The company's strategy is built on a combination of strong internal R&D, strategic acquisitions, and a vast global commercial footprint. Financially robust, Stryker is a revenue-generating commercial-stage company with a proven track record of growth and profitability.
View full company profileTherapeutic Areas
Other Minimally Invasive Surgery Drugs
| Drug | Company | Phase |
|---|---|---|
| Surgical Sealant for Laparoscopic Surgery | Advanced Medical Solutions Group | Development |